Chemours Free Cash Flow vs Invested Capital Analysis

CC Stock

USD 27.08 0.35 1.31%

Chemours financial indicator trend analysis is way more than just evaluating Chemours prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Chemours is a good investment. Please check the relationship between Chemours Free Cash Flow and its Invested Capital accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Chemours Co. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators.

Free Cash Flow vs Invested Capital

Free Cash Flow vs Invested Capital Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Chemours Free Cash Flow account and Invested Capital. At this time, the significance of the direction appears to have strong contrarian relationship.

The correlation between Chemours' Free Cash Flow and Invested Capital is -0.52. Overlapping area represents the amount of variation of Free Cash Flow that can explain the historical movement of Invested Capital in the same time period over historical financial statements of Chemours Co, assuming nothing else is changed. The correlation between historical values of Chemours' Free Cash Flow and Invested Capital is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Free Cash Flow of Chemours Co are associated (or correlated) with its Invested Capital. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Invested Capital has no effect on the direction of Free Cash Flow i.e., Chemours' Free Cash Flow and Invested Capital go up and down completely randomly.

Correlation Coefficient

-0.52

Relationship Direction	Negative
Relationship Strength	Very Weak

View All Relationships

Free Cash Flow

The amount of cash a company generates after accounting for cash outflows to support operations and maintain its capital assets.

Invested Capital

Invested capital represents the total cash investment that shareholders and debt holders have contributed to Chemours Co. There are two different methods for calculating Chemours invested capital: operating approach and financing approach. Understanding Chemours invested capital allows investors to calculate measures of performance such as return on invested capital or return on capital employed.

Most indicators from Chemours' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Chemours current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Chemours Co. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators.

At present, Chemours' Enterprise Value Multiple is projected to increase significantly based on the last few years of reporting.

	2021	2022	2023	2024 (projected)
Gross Profit	1.4B	1.6B	1.3B	1.2B
Total Revenue	6.3B	6.8B	6.0B	5.1B

Gross Profit Total Revenue

Chemours fundamental ratios Correlations

	Common Stock Shares Outstanding	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Property Plant And Equipment Net	Current Deferred Revenue	Accounts Payable	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Long Term Debt	Net Receivables	Good Will	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Short Term Debt	Intangible Assets	Property Plant Equipment	Net Tangible Assets
Common Stock Shares Outstanding		-0.67	-0.75	-0.64	0.36	-0.63	-0.71	-0.05	-0.44	-0.79	-0.21	-0.6	-0.41	0.85	0.73	-0.46	-0.68	0.37	0.68	-0.51	-0.69	-0.52	0.26	0.61	-0.7	0.37
Total Assets	-0.67		0.79	0.83	-0.71	0.86	0.76	-0.08	0.68	0.86	0.37	0.87	0.84	-0.5	-0.91	0.86	0.63	-0.02	-0.92	0.9	0.72	0.95	-0.72	-0.64	0.76	-0.72
Other Current Liab	-0.75	0.79		0.85	-0.73	0.79	0.51	0.14	0.47	0.62	0.32	0.76	0.74	-0.5	-0.84	0.75	0.39	-0.23	-0.84	0.8	0.56	0.79	-0.67	-0.7	0.56	-0.74
Total Current Liabilities	-0.64	0.83	0.85		-0.59	0.84	0.43	0.27	0.69	0.58	0.4	0.92	0.64	-0.39	-0.89	0.66	0.63	-0.13	-0.74	0.75	0.79	0.86	-0.55	-0.68	0.52	-0.57
Total Stockholder Equity	0.36	-0.71	-0.73	-0.59		-0.82	-0.47	-0.11	-0.23	-0.54	-0.35	-0.67	-0.97	0.27	0.71	-0.96	-0.08	-0.25	0.88	-0.95	-0.33	-0.72	0.91	0.47	-0.46	0.99
Other Liab	-0.63	0.86	0.79	0.84	-0.82		0.58	0.14	0.55	0.72	0.5	0.9	0.85	-0.42	-0.89	0.87	0.58	0.1	-0.89	0.91	0.71	0.84	-0.73	-0.61	0.62	-0.8
Property Plant And Equipment Net	-0.71	0.76	0.51	0.43	-0.47	0.58		-0.22	0.31	0.97	0.02	0.47	0.6	-0.69	-0.59	0.64	0.51	0.05	-0.71	0.63	0.46	0.53	-0.36	-0.53	0.96	-0.51
Current Deferred Revenue	-0.05	-0.08	0.14	0.27	-0.11	0.14	-0.22		0.13	-0.12	0.46	0.26	-0.02	-0.01	-0.13	-0.01	0.05	0.1	0.0	0.03	0.15	-0.04	-0.09	-0.19	-0.27	-0.11
Accounts Payable	-0.44	0.68	0.47	0.69	-0.23	0.55	0.31	0.13		0.48	0.67	0.7	0.37	-0.09	-0.69	0.39	0.79	0.06	-0.5	0.46	0.73	0.71	-0.41	-0.5	0.33	-0.25
Non Current Assets Total	-0.79	0.86	0.62	0.58	-0.54	0.72	0.97	-0.12	0.48		0.24	0.65	0.67	-0.71	-0.74	0.71	0.64	0.03	-0.8	0.72	0.62	0.66	-0.48	-0.63	0.92	-0.58
Non Currrent Assets Other	-0.21	0.37	0.32	0.4	-0.35	0.5	0.02	0.46	0.67	0.24		0.6	0.36	0.01	-0.49	0.36	0.46	0.26	-0.39	0.38	0.47	0.4	-0.54	-0.41	-0.08	-0.36
Other Assets	-0.6	0.87	0.76	0.92	-0.67	0.9	0.47	0.26	0.7	0.65	0.6		0.74	-0.44	-0.93	0.76	0.65	-0.04	-0.82	0.82	0.84	0.88	-0.7	-0.66	0.48	-0.65
Long Term Debt	-0.41	0.84	0.74	0.64	-0.97	0.85	0.6	-0.02	0.37	0.67	0.36	0.74		-0.33	-0.78	1.0	0.22	0.22	-0.94	0.99	0.42	0.83	-0.92	-0.5	0.58	-0.97
Net Receivables	0.85	-0.5	-0.5	-0.39	0.27	-0.42	-0.69	-0.01	-0.09	-0.71	0.01	-0.44	-0.33		0.56	-0.37	-0.46	0.4	0.57	-0.39	-0.55	-0.31	0.16	0.39	-0.59	0.27
Good Will	0.73	-0.91	-0.84	-0.89	0.71	-0.89	-0.59	-0.13	-0.69	-0.74	-0.49	-0.93	-0.78	0.56		-0.81	-0.62	0.13	0.91	-0.86	-0.87	-0.9	0.73	0.68	-0.59	0.71
Non Current Liabilities Total	-0.46	0.86	0.75	0.66	-0.96	0.87	0.64	-0.01	0.39	0.71	0.36	0.76	1.0	-0.37	-0.81		0.27	0.21	-0.95	0.99	0.47	0.84	-0.91	-0.52	0.62	-0.96
Inventory	-0.68	0.63	0.39	0.63	-0.08	0.58	0.51	0.05	0.79	0.64	0.46	0.65	0.22	-0.46	-0.62	0.27		-0.12	-0.45	0.34	0.79	0.54	-0.12	-0.37	0.52	-0.08
Other Current Assets	0.37	-0.02	-0.23	-0.13	-0.25	0.1	0.05	0.1	0.06	0.03	0.26	-0.04	0.22	0.4	0.13	0.21	-0.12		-0.02	0.16	-0.21	-0.05	-0.16	-0.11	0.01	-0.27
Other Stockholder Equity	0.68	-0.92	-0.84	-0.74	0.88	-0.89	-0.71	0.0	-0.5	-0.8	-0.39	-0.82	-0.94	0.57	0.91	-0.95	-0.45	-0.02		-0.96	-0.62	-0.87	0.84	0.57	-0.67	0.88
Total Liab	-0.51	0.9	0.8	0.75	-0.95	0.91	0.63	0.03	0.46	0.72	0.38	0.82	0.99	-0.39	-0.86	0.99	0.34	0.16	-0.96		0.54	0.88	-0.89	-0.57	0.63	-0.94
Property Plant And Equipment Gross	-0.69	0.72	0.56	0.79	-0.33	0.71	0.46	0.15	0.73	0.62	0.47	0.84	0.42	-0.55	-0.87	0.47	0.79	-0.21	-0.62	0.54		0.68	-0.38	-0.61	0.47	-0.31
Total Current Assets	-0.52	0.95	0.79	0.86	-0.72	0.84	0.53	-0.04	0.71	0.66	0.4	0.88	0.83	-0.31	-0.9	0.84	0.54	-0.05	-0.87	0.88	0.68		-0.77	-0.57	0.57	-0.71
Short Term Debt	0.26	-0.72	-0.67	-0.55	0.91	-0.73	-0.36	-0.09	-0.41	-0.48	-0.54	-0.7	-0.92	0.16	0.73	-0.91	-0.12	-0.16	0.84	-0.89	-0.38	-0.77		0.41	-0.32	0.92
Intangible Assets	0.61	-0.64	-0.7	-0.68	0.47	-0.61	-0.53	-0.19	-0.5	-0.63	-0.41	-0.66	-0.5	0.39	0.68	-0.52	-0.37	-0.11	0.57	-0.57	-0.61	-0.57	0.41		-0.55	0.5
Property Plant Equipment	-0.7	0.76	0.56	0.52	-0.46	0.62	0.96	-0.27	0.33	0.92	-0.08	0.48	0.58	-0.59	-0.59	0.62	0.52	0.01	-0.67	0.63	0.47	0.57	-0.32	-0.55		-0.49
Net Tangible Assets	0.37	-0.72	-0.74	-0.57	0.99	-0.8	-0.51	-0.11	-0.25	-0.58	-0.36	-0.65	-0.97	0.27	0.71	-0.96	-0.08	-0.27	0.88	-0.94	-0.31	-0.71	0.92	0.5	-0.49

Click cells to compare fundamentals

Chemours Account Relationship Matchups

Chemours fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Common Stock Shares Outstanding	164.8M	166.3M	168.7M	158.3M	148.9M	140.1M
Total Assets	7.3B	7.1B	7.6B	7.6B	8.3B	7.5B
Other Current Liab	477M	537M	668M	554M	1.2B	1.3B
Total Current Liabilities	1.5B	1.4B	1.9B	1.9B	2.5B	1.8B
Total Stockholder Equity	689M	813M	1.1B	1.1B	737M	1.1B
Other Liab	751M	626M	707M	854M	982.1M	711.9M
Property Plant And Equipment Net	3.9B	3.7B	3.4B	3.4B	3.5B	3.6B
Accounts Payable	923M	820M	1.2B	1.3B	1.1B	1.1B
Non Current Assets Total	4.5B	4.4B	4.2B	4.4B	4.4B	4.4B
Non Currrent Assets Other	391M	252M	310M	573M	374M	416.1M
Other Assets	292M	405M	547M	725M	833.8M	424.1M
Long Term Debt	4.0B	4.0B	3.7B	3.6B	4.0B	3.2B
Net Receivables	674M	511M	720M	626M	610M	602.4M
Liabilities And Stockholders Equity	7.3B	7.1B	7.6B	7.6B	8.3B	7.5B
Non Current Liabilities Total	5.0B	4.8B	4.6B	4.6B	5.0B	4.1B
Inventory	1.1B	939M	1.1B	1.4B	1.4B	1.2B
Other Current Assets	81M	78M	75M	82M	66M	64.8M
Other Stockholder Equity	(213M)	(182M)	(303M)	(722M)	(773M)	(734.4M)
Total Liab	6.6B	6.3B	6.5B	6.5B	7.5B	6.0B
Property Plant And Equipment Gross	3.9B	3.7B	9.2B	9.4B	9.6B	5.2B
Total Current Assets	2.8B	2.6B	3.3B	3.2B	3.8B	3.0B
Accumulated Other Comprehensive Income	(349M)	(310M)	(364M)	(343M)	(274M)	(287.7M)
Short Term Debt	13M	134M	78M	25M	106M	86.1M
Intangible Assets	28M	21M	14M	6M	3M	2.9M
Property Plant Equipment	3.9B	3.5B	3.4B	3.2B	3.6B	3.5B
Net Tangible Assets	515M	646M	973M	992M	892.8M	710.5M
Retained Earnings	1.2B	1.3B	1.7B	2.2B	1.8B	1.1B
Cash	943M	1.1B	1.5B	1.1B	1.8B	1.2B
Deferred Long Term Liab	148M	36M	49M	61M	54.9M	96.1M
Long Term Investments	162M	167M	169M	175M	158M	171.6M
Short Long Term Debt	13M	134M	21M	25M	51M	41.5M
Short Long Term Debt Total	4.4B	4.3B	3.9B	3.8B	4.3B	4.4B
Net Debt	3.5B	3.2B	2.5B	2.7B	2.5B	2.3B
Cash And Short Term Investments	943M	1.1B	1.5B	1.1B	1.8B	1.3B
Retained Earnings Total Equity	1.2B	1.3B	1.7B	2.2B	2.5B	2.6B
Long Term Debt Total	4.0B	4.0B	3.7B	3.6B	3.2B	3.1B
Capital Surpluse	859M	890M	944M	1.0B	1.2B	958.4M

Pair Trading with Chemours

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Chemours position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Chemours will appreciate offsetting losses from the drop in the long position's value.

Moving against Chemours Stock

0.59	DNMR	Danimer Scientific Financial Report 8th of May 2024	Pair Corr
0.58	ECL	Ecolab Inc Earnings Call This Week	Pair Corr
0.55	CMT	Core Molding Technologies Financial Report 14th of May 2024	Pair Corr
0.53	ASH	Ashland Global Holdings Earnings Call This Week	Pair Corr
0.5	CBT	Cabot Financial Report 13th of May 2024	Pair Corr

The ability to find closely correlated positions to Chemours could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Chemours when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Chemours - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Chemours Co to buy it.

The correlation of Chemours is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Chemours moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Chemours moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Chemours can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

When determining whether Chemours offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Chemours' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Chemours Co Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Chemours Co Stock:

How To Invest In Chemours

Details

Is Chemours Stock a good investment?

Details

What is Chemours' Net Worth?

Details

Largest Specialty Chemicals Companies

View

Largest Basic Materials Companies

View

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Chemours Co. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators.

Note that the Chemours information on this page should be used as a complementary analysis to other Chemours' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.

Complementary Tools for Chemours Stock analysis

When running Chemours' price analysis, check to measure Chemours' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chemours is operating at the current time. Most of Chemours' value examination focuses on studying past and present price action to predict the probability of Chemours' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Chemours' price. Additionally, you may evaluate how the addition of Chemours to your portfolios can decrease your overall portfolio volatility.

	Portfolio Anywhere Track or share privately all of your investments from the convenience of any device
	Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
	Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
	ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
	Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges
	Fundamental Analysis View fundamental data based on most recent published financial statements
	Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
	Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios.
	Stocks Directory Find actively traded stocks across global markets
	AI Investment Finder Use AI to screen and filter profitable investment opportunities

Is Chemours' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Chemours. If investors know Chemours will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Chemours listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.91)

Dividend Share

Earnings Share

(1.60)

Revenue Per Share

40.473

Quarterly Revenue Growth

0.017

The market value of Chemours is measured differently than its book value, which is the value of Chemours that is recorded on the company's balance sheet. Investors also form their own opinion of Chemours' value that differs from its market value or its book value, called intrinsic value, which is Chemours' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Chemours' market value can be influenced by many factors that don't directly affect Chemours' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Chemours' value and its price as these two are different measures arrived at by different means. Investors typically determine if Chemours is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Chemours' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Chemours Free Cash Flow vs Invested Capital Analysis

Free Cash Flow vs Invested Capital

Free Cash Flow vs Invested Capital Correlation Analysis

Correlation Coefficient

Free Cash Flow

Invested Capital

Chemours fundamental ratios Correlations

Chemours Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Chemours fundamental ratios Accounts

Pair Trading with Chemours

Moving against Chemours Stock

Complementary Tools for Chemours Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Non Current Liabilities Total	+ 1.0	Long Term Debt
Net Tangible Assets	+ 0.99	Total Stockholder Equity
Total Liab	+ 0.99	Long Term Debt
Total Liab	+ 0.99	Non Current Liabilities Total
Non Current Assets Total	+ 0.97	Property Plant And Equipment Net
Property Plant Equipment	+ 0.96	Property Plant And Equipment Net

Net Tangible Assets	- 0.97	Long Term Debt
Long Term Debt	- 0.97	Total Stockholder Equity
Total Liab	- 0.96	Other Stockholder Equity
Net Tangible Assets	- 0.96	Non Current Liabilities Total
Non Current Liabilities Total	- 0.96	Total Stockholder Equity
Other Stockholder Equity	- 0.95	Non Current Liabilities Total